FSAGX | OCMGX | FSAGX / OCMGX | |
Total Expense Ratio | 0.68 | 2.38 | 29% |
Annual Report Gross Expense Ratio | 0.68 | 2.38 | 29% |
Fund Existence | 40 years | 38 years | - |
Gain YTD | 93.043 | 102.441 | 91% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.85B | 150M | 1,897% |
Annual Yield % from dividends | 1.88 | 1.14 | 165% |
Returns for 1 year | 83.18 | 80.89 | 103% |
Returns for 3 years | 169.68 | 196.95 | 86% |
Returns for 5 years | 56.11 | 78.66 | 71% |
Returns for 10 years | 295.18 | 240.79 | 123% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DFSGX | 25.42 | 0.36 | +1.44% |
DF Dent Small Cap Growth Institutional | |||
VTAIX | 11.24 | 0.03 | +0.27% |
Virtus Tactical Allocation I | |||
LMOPX | 40.43 | -0.03 | -0.07% |
Patient Opportunity C | |||
AVPEX | 13.74 | -0.02 | -0.15% |
ALPS Global Opportunity Portfolio Cl III | |||
FCAKX | 47.08 | -0.17 | -0.36% |
Fidelity Capital Appreciation K |